March, 25 2021, 12:00am EDT

For Immediate Release
Contact:
Fabiola Nuñez, NRDC, (786) 999-2138, fnunez@nrdc.org
Nathan Donley, Center for Biological Diversity, (971) 717-6406, ndonley@biologicaldiversity.org
Matt Wellington, U.S. PIRG, (845) 591-5646, mwellington@pirg.org
Nydia Gutierrez, Earthjustice, (202) 302-7531, ngutierrez@earthjustice.org
Lawsuit Challenges EPA Approval of the Use of Medically Important Antibiotic as a Pesticide on Citrus Crops
Streptomycin Use Allowed on More Than 650,000 Acres in Florida, California
WASHINGTON
A coalition of public interest groups, including farmworker, health justice and conservation organizations, sued the Environmental Protection Agency (EPA) today for approving widespread spraying of streptomycin, a medically important antibiotic, on citrus trees to prevent or treat citrus greening disease or citrus canker. The practice of spraying antibiotics on trees has proven highly ineffective in combating these diseases, and it can drive antibiotic resistance in bacteria that threaten human health.
The EPA failed to ensure that the approved uses of streptomycin as a pesticide would not cause unreasonable harm to human health or the environment and failed to adequately assess impacts to endangered species, according to the lawsuit.
Streptomycin, which is banned from use on crops in many countries, belongs to a class of antibiotics the World Health Organization (WHO) considers "critically" important to treating human disease, such as multidrug-resistant tuberculosis. The Centers for Disease Control and Prevention and the Food and Drug Administration have expressed concerns about the use of medically important antibiotics as pesticides and have spoken out publicly against it.
"Farmworkers are already exposed to a mix of toxic pesticides in the course of their daily work," said Jeannie Economos, Pesticide Safety and Environmental Health Project Coordinator at Farmworker Association of Florida. "It is unconscionable for EPA to use farmworkers as guinea pigs when it comes to antibiotic-resistant bacteria that risks the health of them and their children. Instead of promoting this risky false solution, EPA should look at effective ways to control citrus diseases that are safe for our food supply and for the essential workers and their families who sustain our food system."
The agency's decision greenlights the use of more than 650,000 pounds of streptomycin on citrus crops in Florida and California alone. By contrast, the United States currently uses only about 14,000 pounds of aminoglycosides, the antibiotic class that includes streptomycin, for medical purposes each year.
The EPA's approval of streptomycin as a pesticide followed a similar approval two years ago of the "highly" important antibiotic oxytetracycline for use on the same citrus crops.
"Allowing life-saving antibiotics to be used as pesticides is an unnecessary and dangerous practice that fuels a growing public health epidemic: antibiotic resistance," said Allison Johnson, Sustainable Food Policy Advocate at NRDC (Natural Resources Defense Council). "The EPA should be championing agricultural practices that protect farm workers and their communities, public health, and the environment-like building healthy soil and diversified farming-not increasing the use of dangerous pesticides."
Recent research suggests that antibiotic resistance is on the rise nationally, with an estimated 162,000 people in the United States dying each year from antibiotic-resistant infections. Furthermore, the misuse of antibiotics has fueled resistance in tuberculosis-causing bacteria; the global TB pandemic still kills more than 1 million people around the world every year.
"To jeopardize an essential tool in controlling the global tuberculosis pandemic by allowing it to be sprayed on citrus trees is the height of irresponsibility," said Nathan Donley, a senior scientist at the Center for Biological Diversity. "Leading global health officials are sounding the alarm about overuse of essential medicines like streptomycin, yet the EPA's pesticide office is recklessly blessing its use as a pesticide."
The WHO ranked antibiotic resistance among the top 10 health threats in 2019.
"The more you use antibiotics, the greater the risk that bacteria resistant to the drugs will flourish and spread. Experts estimate that drug-resistant infections could kill 10 million people globally per year by 2050--nearly four times as many people who have died worldwide from COVID-19," said Matt Wellington, Public Health Campaigns Director for U.S. PIRG. "Spraying medically important antibiotics on citrus crops is absurd under any circumstances, but it's especially absurd when we know it's not going to solve the citrus industry's problems."
The EPA's own analysis indicates that the widespread use of streptomycin could also have harmful long-term effects on mammals that forage in treated fields. The agency has not analyzed how this change could affect specific endangered and threatened mammals that forage or nest in and around these citrus groves, or that rely on waterways contaminated by the antibiotic. Nor has EPA adequately assessed the risk that streptomycin poses to pollinators, whose health and survival are already compromised by a wide range of stressors, including other pesticides.
Today's lawsuit was filed in the 9th Circuit Court of Appeals by Beyond Pesticides, Center for Biological Diversity, Environmental Confederation of Southwest Florida (ECOSWF), Farmworker Association of Florida, Farmworker Justice, Migrant Clinicians Network, NRDC and U.S. PIRG. Parties are represented by in-house counsel and Earthjustice.
More information available here.
NRDC works to safeguard the earth--its people, its plants and animals, and the natural systems on which all life depends. We combine the power of more than three million members and online activists with the expertise of some 700 scientists, lawyers, and policy advocates across the globe to ensure the rights of all people to the air, the water, and the wild.
(212) 727-2700LATEST NEWS
Sanders Gets GOP Leader to Agree to Work On Medicare Covering Dental, Hearing, and Vision
The exchange on the Senate floor came after the Finance Committee chair blocked passage of the Vermont Independent's bill.
Mar 11, 2025
U.S. Senate Finance Committee Chair Mike Crapo on Tuesday blocked passage of Sen. Bernie Sanders' legislation to expand Medicare to cover dental, hearing, and vision care for tens of millions of American seniors, but the bill's sponsor got the panel leader to publicly agree to further discuss the issue.
Sanders (I-Vt.) took to the Senate floor Tuesday afternoon to ask for unanimous consent to pass the Medicare Dental, Hearing, and Vision Expansion Act, which is spearheaded in the House of Representatives by Congressman Lloyd Doggett (D-Texas).
"In the richest country in the history of the world, it is unacceptable that millions of seniors are unable to read because they can't afford eyeglasses, can't have conversations with their grandchildren because they can't afford hearing aids, and have trouble eating because they can't afford dentures," Sanders said in a statement.
"That should not be happening in the United States of America in the year 2025," he continued. "The time is long overdue for Congress to expand Medicare to include comprehensive coverage for the dental, vision, and hearing care that our seniors desperately need."
After Crapo (R-Idaho) rose to stop the bill from advancing, he and Sanders had a brief exchange in which the Republican agreed to working on achieving the "outcome" of the federal healthcare program covering dental, vision, and hearing.
In Sanders' remarks on the Senate floor about his bill, he sounded the alarm about efforts by President Donald Trump, billionaire Elon Musk, and congressional Republicans to cut government healthcare programs and Social Security.
"Yeah, we have more nuclear weapons than any other country, we have more billionaires than any other country, but we also have one of the highest rates of senior poverty of any country on Earth. We might want to get our priorities right," said Sanders, who has long fought for achieving universal healthcare in the United States via his Medicare for All legislation.
"While my Republican colleagues would like to make massive cuts to Medicaid in order to provide more tax breaks to billionaires, some of us have a better idea," he said. "We think that it makes more sense to substantially improve the lives of our nation's seniors by expanding Medicare to cover dental, vision, and hearing benefits."
To pay for his expansion plan, Sanders calls for ensuring that Medicare pays no more for prescription drugs than the Department of Veterans Affairs and addressing the tens of billions of dollars that privately administered Medicare Advantage plans overcharge the federal government annually.
In a statement about the bill, Doggett highlighted that "this expanded care could help prevent cognitive impairment and dementia, worsened chronic disease, and imbalance leading to falls with deadly consequences. This is an essential step to fulfilling the original promise of Medicare—to assure dignity and health for all."
Welcoming their renewed push for Medicare expansion, Public Citizen healthcare advocate Eagan Kemp declared that "at the same time Trump and his cronies in Congress try to rip healthcare away from millions and push for further privatization of Medicare, Sen. Sanders and Rep. Doggett are showing what one of our top priorities in healthcare should be—improving traditional Medicare."
"The introduction of this legislation is an important step to ensure Medicare enrollees can access the care they need, and we hope that Congress will act quickly to pass these commonsense reforms," Kemp added. "Healthcare is a human right."
Earlier Tuesday, in anticipation of Crapo's committee holding a confirmation hearing for Dr. Mehmet Oz, the former television host Trump has nominated to lead the Centers for Medicare and Medicaid, Public Citizen released a research brief about the hundreds of millions of dollars Medicare Advantage companies have spent on lobbying.
"If Oz is confirmed as the CMS administrator," Kemp warned, "attacks on traditional Medicare are likely to move into overdrive."
Keep ReadingShow Less
Trump Lifts Ukraine Aid Pause After Kyiv Agrees to Cease-Fire Proposal
Ukraine's foreign minister called the endorsement a "step that proves Ukraine is ready to move forward on the path to a just end to the war."
Mar 11, 2025
The Trump administration said Tuesday that it would resume military aid to and intelligence-sharing with Ukraine after that country's leadership endorsed a U.S. proposal for a 30-day cease-fire in the war defending against Russia's three-year invasion and occupation.
The Washington Postreports that U.S., Ukrainian, and Saudi officials met for eight hours on Tuesday in Jeddah, Saudi Arabia. No Russian officials were present at the negotiations.
"We're going to tell them this is what's on the table. Ukraine is ready to stop shooting and start talking," U.S. Secretary of State Marco Rubio said after the meeting. "And now it'll be up to them to say yes or no. If they say no, then we'll unfortunately know what the impediment is to peace here."
Ukraine has agreed to a 30 day ceasefire. Incredible work by Trump team. Now if Russia agrees, Trump may have gotten cease fires in the Middle East and Europe in his first 60 days. Nobel Peace Prize worthy: pic.twitter.com/lYogXVP8wj
— Clay Travis (@ClayTravis) March 11, 2025
White House National Security Adviser Michael Waltz said following the talks that "the Ukrainian delegation today made something very clear, that they share President [Donald] Trump's vision for peace, they share his determination to end the fighting, to end the killing, to end the tragic meat grinder of people."
Ukrainian Foreign Minister Andrii Sybiha called his country's endorsement of the cease-fire proposal a "step that proves Ukraine is ready to move forward on the path to a just end to the war."
"Ukraine is not an obstacle to peace; it is a partner in its restoration," Sybiha added.
U.S. officials said the cease-fire proposal will now be sent to Russia for approval. It is unclear whether Russian President Vladimir Putin will accept the offer.
"The ball is now in their court," Rubio said of the Russians.
Buoyed by Western support but stretched thin and vastly outmanned and outgunned, Ukrainian forces have been struggling to repel Russia's invasion and hold Russian territory they seized in the Kursk region, with an eye toward potential future territorial exchanges.
On Tuesday, Ukrainian forces launched a massive drone attack on Moscow. Three people were reportedly killed and six others were injured when debris struck a meat processing facility.
Tuesday's development marked a dramatic turnaround from just two weeks ago, when Trump and Vice President JD Vance lambasted Ukrainian President Volodymyr Zelenskyy during a highly contentious White House meeting that was followed by a suspension of all U.S. military assistance and intelligence-sharing with Kyiv.
The U.S. has "provided $66.5 billion in military assistance since Russia launched its premeditated, unprovoked, and brutal full-scale invasion of Ukraine on February 24, 2022, and approximately $69.2 billion in military assistance since Russia's initial invasion of Ukraine in 2014," according to a State Department fact sheet dated March 4.
Keep ReadingShow Less
Watchdog Exposes Millions in Medicare Advantage Lobbying Ahead of Dr. Oz Hearing
"If Oz is confirmed as the CMS administrator, attacks on traditional Medicare are likely to move into overdrive," said one advocate, calling to strengthen the program, "not weaken it through further privatization."
Mar 11, 2025
The watchdog group Public Citizen on Tuesday released a research brief about the hundreds of millions of dollars Medicare Advantage companies have spent on lobbying ahead of a U.S. Senate confirmation hearing for Dr. Mehmet Oz.
Oz, a heart surgeon and former television host, is President Donald Trump's nominee to run the Centers for Medicare and Medicaid (CMS)—an agency in the U.S. Department of Health and Human Services, which is led by conspiracy theorist Robert F. Kennedy Jr.
Health experts and others have sounded the alarm about Oz since Trump announceded his nomination in November, with many opponents highlighting the doctor's investments in companies with direct CMS interests and his push to expand Medicare Advantage when he unsuccessfully ran as a Republican to represent Pennsylvania in the U.S. Senate in 2022.
Medicare Advantage is a type of CMS-approved health insurance plan from a private company that seniors can choose for medical coverage instead of government-administered Medicare. Critics often call it a "profit-seeking healthcare scam."
Public Citizen's brief points out that last year, "more than half of all seniors eligible for Medicare were enrolled" in these private plans that "cost taxpayers hundreds of billions of dollars and deliver inferior care compared to traditional Medicare."
"Since their inception in 2003, Medicare Advantage plans are estimated to have cost taxpayers more than $600 billion in overpayments," the document notes. "These overpayments are expected to grow to $1 trillion over the next decade."
"Just seven companies account for 84% of all Medicare Advantage enrollment," the brief continues. "While lobbying disclosures do not reveal how much is spent on a single issue, disclosures reveal that these seven companies spent more than $330 million combined lobbying on all issues over the last five years, according to data from OpenSecrets."
Those companies are UnitedHealthcare, Humana, Blue Cross Blue Shield, CVS Health, Kaiser, Centene, and Cigna.
Public Citizen found that in 2024, they collectively had 328 lobbyists targeting the federal government, with nearly 70% of them specifically working on Medicare Advantage. Blue Cross had the most lobbyists focused on such plans (99), followed by Humana (33) and UnitedHealth Group (27).
"If Oz is confirmed as the CMS administrator, attacks on traditional Medicare are likely to move into overdrive," Eagan Kemp, a healthcare policy advocate at Public Citizen, warned in a Tuesday statement. "We should strengthen Medicare by improving it and expanding access to it, not weaken it through further privatization."
The Senate Committee on Finance is set to consider Oz on Friday morning. Since Trump returned to the White House in January, the GOP-controlled chamber hasn't blocked any of his nominees.
Keep ReadingShow Less
Most Popular